Biotech Demonstrates Superiority of Polyp-Detecting Product
Source: Streetwise Reports  (7/17/19)
The study results and their meaning are reviewed in an H.C. Wainwright & Co. report. More >

Biotech Incorporates Urologists' Feedback Into Device Design
Source: Streetwise Reports  (7/17/19)
This step moves the product further down the development track. More >

Health Technology Company Recuperating Well
Source: Clive Maund for Streetwise Reports  (7/3/19)
Technical analyst Clive Maund charts a medical technology firm and explains why he believes it is an interesting speculative play. More >

Biotech Receives FDA Approval of Second-Generation Medical Device
Source: Streetwise Reports  (6/12/19)
The product's improvements and the company's commercialization approach were summarized in a Ladenburg Thalmann report. More >

Women's Wellness Device Developer Posts In-Line Quarter, Catalysts Looming
Source: Streetwise Reports  (5/15/19)
A review of this Colorado company's first numbers of the year was provided in a Ladenburg Thalmann report. More >

Augmented Reality Firm Moves into Medical Devices Arena
Source: Streetwise Reports  (4/9/19)
This technology company continues to diversify the end markets for its e-commerce platform. More >

Firm Launches App to Help Physicians Provide Virtual Counseling
Source: Streetwise Reports  (3/5/19)
This new initiative combines emerging technologies and human skill-based expertise. More >

Medical Device Firm Develops Nitric Oxide Delivery Unit for Clinic Use
Source: Streetwise Reports  (2/6/19)
This new machine takes the company's product line count to four. More >

Health Stock 'Looking Set to Bounce Back After 90% Drop'
Source: Clive Maund for Streetwise Reports  (12/11/18)
Technical analyst Clive Maund charts a telemedicine technology company and explains why he believes the company's stock should rebound. More >

Neuromonitoring Stock 'Ready to Rally'
Source: Clive Maund for Streetwise Reports  (11/26/18)
Technical analyst Clive Maund charts a neuromonitoring company that he believes is undervalued. More >

Biotech Files Patent Application for Nitric Oxide Delivery Device
Source: Streetwise Reports  (11/16/18)
With this development, the company advances blood/plasma transfusion technology.
More >

Developer of Nitric Oxide Delivery Devices Rebrands to Focus on Leading Advancements
Source: Streetwise Reports  (10/9/18)
This Utah-based company rolled out an online campaign that highlights its strategic repositioning. More >

Company with Cancer Radiotherapy Grows Revenue for Six Consecutive Quarters
Source: Streetwise Reports  (10/3/18)
An H.C. Wainwright & Co. report reviewed this company's Q4/18 earnings and opportunities for increasing it. More >

Surgical Robotics Developer Demonstrates Technology at Medical Conference
Source: Streetwise Reports  (10/3/18)
A Ladenburg Thalmann report relayed how this Massachusetts company participated at the Transcatheter Cardiovascular Therapeutics annual meeting through a live transmission—the first ever—of a remote interventional procedure using the CorPath GRX system. More >

Coverage Initiated on Firm with Paradigm-Shifting Colonoscopy Device
Source: Streetwise Reports  (9/5/18)
A Ladenburg Thalmann report covered the asset, product market and financial projections of this Florida-based company. More >

Medical Device Firm Anticipates Benefit from Patent Ruling
Source: Streetwise Reports  (8/15/18)
This company, which develops delivery products for inhaled nitric oxide, a gas used to treat newborns with low oxygen levels and patients with COPD, sees opportunity in a newly invalidated patent. More >

Medical Device Firm's Clinical Programs Progress in Q2/18
Source: Streetwise Reports  (8/15/18)
A Ladenburg Thalmann report reviewed the recent financial results for a California-based company that has developed treatments for vaginal laxity and female stress urinary incontinence. More >

Interim Readout for Pharma Trial 'Delivers Home Run'
Source: Streetwise Reports  (7/31/18)
An H.C. Wainwright & Co. report discussed the implications of data indicating "overwhelming evidence of efficacy" for this company's nonantibiotic anti-infective for treatment of catheter-related bloodstream infections. More >

Agreement Facilitates Progress Toward Medical Device Approvals
Source: Streetwise Reports  (6/20/18)
This medical device company enters a partnership to provide quality and regulatory services. More >

Coverage Initiated on Developer of Women's Reproductive Health Products
Source: Streetwise Reports  (5/30/18)
A ROTH Capital Partners research report outlined the key drivers of the investment thesis for this firm. More >

Analyst: 'New CEO, Larger Sales Team and Greater SUI Focus Should Help Medical Device Growth'
Source: Streetwise Reports  (5/23/18)
Cowen analyst Dr. Joshua Jennings highlighted this medical device firm's Q1/18 developments and financial results. More >

What Stephen Hawking Missed: Small Biotechs Developing Promising Cell Therapies for Devastating Disease
Source: Streetwise Reports  (5/2/18)
In the second of a two-part series exploring the disruptive cell therapy space, Maxim Group analyst Jason McCarthy takes a look at small-cap companies targeting big-ticket indications and their potential to drive blockbuster value for both patients and investors. More >

Medical Device Firm Posts 'Strong Performance' Globally in Q4/17
Source: Streetwise Reports   (3/28/18)
The company performed strongly in the U.S. and the Asia Pacific region. More >

Convergence Will Drive the Ultimate Disruption of Life Sciences
Source: Andrea Bartzen for Streetwise Reports  (3/28/18)
Andrea Bartzen, a strategic commercial and communication consultant, describes the disruptive technologies positioned to radically alter the business of life sciences as discussed at a recent BIO CEO Summit Investor Night.
More >

Medical Device Firm to Launch Trials for Treatment Targeting $12 Billion Incontinence Market
Source: Streetwise Reports  (2/14/18)
Anthony Vendetti, an analyst with Maxim Group, shared the results both of a pilot study for stress urinary incontinence and of a recent equity raise by this company.
More >